OX2 Therapeutics

OX2 Therapeutics Overview

  • Founded
  • 2016
Founded
  • Status
  • Private
  • Employees
  • 7
Employees
  • Latest Deal Type
  • Series A
  • (Cancelled)
  • Latest Deal Amount
  • $2M
Latest Deal Amount

OX2 Therapeutics General Information

Description

Owner and operator of a healthcare therapeutics company intended to treat primary brain tumors. The company designs and develops a novel CD200 Checkpoint peptide inhibitor that activates the immune system through a CD200 activation receptor, enabling healthcare companies to apply receptor antibodies that permit the immune system army to pass through blood vessel walls and kill cancer activities.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Angel-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 16632 Iredale Path
  • Lakeville, MN 55044
  • United States
+1 (612) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

OX2 Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Angel (individual) 18-May-2017 $2M Cancelled Startup
2. Angel (individual) 17-May-2017 00000 00000 Completed Startup
1. Grant $2M Completed Startup

OX2 Therapeutics Executive Team (4)

Name Title Board Seat Contact Info
Jeff Liter President, Interim Chief Financial Officer & Interim Chief Executive Officer
Michael Olin Ph.D Chief Scientific Officer, Co-Founder & Board Member
Christopher Moertel MD Co-Founder & Chief Medical Officer
Sumant Dhawan Vice President of Operations, Co-Founder & Board Member

OX2 Therapeutics Board Members (4)

Name Representing Role Since
Ben Oehler OX2 Therapeutics Board Member 000 0000
Michael Olin Ph.D OX2 Therapeutics Chief Scientific Officer, Co-Founder & Board Member 000 0000
Sumant Dhawan OX2 Therapeutics Vice President of Operations, Co-Founder & Board Member 000 0000
Thomas Martinson OX2 Therapeutics Board Member 000 0000

Ready to get started?

Request a free trial